Published on : Nov 28, 2018
Albany, New York, November 28, 2018: Drug eluting balloon is basically a semi-compliant angioplasty balloon, which is coated using anti-proliferative medicine. This particular medicine is passed onto the vessel walls at the time of balloon inflation. Over the years, this device has gained significant popularity since it helps in the operative treatment of in-stent restenosis. Market Research Hub (MRH) has included a new study titled “Drug Eluting Balloon Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026”, which delivers a clear insight about the overall revenue status as well as market size details associated to the global drug eluting balloon market. As per research findings, the target market was valued at US$ 420 Mn in 2017, and is expected to reach US$ 1800 Mn by the end of 2026. At this pace, the concerned market is likely to expand at an impressive 18% CAGR during 2018 to 2026.
According to report specifics, the development of the global drug eluting balloon market can be attributed to several factors such as growth in geriatric population, threats of cardiovascular diseases, huge patient base situated across developing countries as well as investments by public and private market players concerned with R&D to treat peripheral and coronary artery diseases using drug eluting balloons. The research report covers all such market drivers, together with restraints and challenges which can impact the growth of the concerned drug eluting balloon market in the coming years. This assessment later includes a separate section termed as market outlook, which includes key market trends along with key mergers & acquisitions occurring in the drug eluting balloon sector.
As the report proceeds, readers can gain insight about the market segmentation presented in terms of product, end-user, drug coating technology and region. On the basis of product, the global market is classified into peripheral drug eluting balloons, coronary drug eluting balloons and others. Furthermore, based on drug coating technology, the target market is bifurcated into Paccocath, TransPax, FreePac, EnduraCoat, and others. The primary end-use segments mentioned in the assessment are hospitals and ambulatory surgical centers, CATH labs, and others. Each of these segments are studied in terms of market value forecast and market attractiveness.
The final section of the report is dedicated to highlight the competitive scenario prevailing in the global drug eluting balloon market. Some of the major players from the industry are enclosed so as to give a brief insight about their strategy and development plans during the forecast period. Medtronic, Becton, Boston Scientific Corporation, Dickinson and Company (BD), B. Braun Melsungen AG, Cook Medical, Koninklijke Philips N.V., Terumo Corporation, Opto Circuits (India) Limited, Biotronik and Surmodics, Inc, are the prominent players examined in this smart report.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=206084
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org